Last update 14 Jun 2025

Allopurinol/Tranilast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tranilast/allopurinol, NU-1618
Target
XO
Action
inhibitors
Mechanism
XO inhibitors(Xanthine dehydrogenase inhibitors)
Therapeutic Areas
Immune System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication-
Inactive Indication
Hyperuricemia
Originator Organization
Nuon Therapeutics, Inc.Nuon Therapeutics, Inc.
Active Organization-
Inactive Organization
Nuon Therapeutics, Inc.Nuon Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H17NO5
InChIKeyNZHGWWWHIYHZNX-UHFFFAOYSA-N
CAS Registry53902-12-8
View All Structures (2)

Related

2
Clinical Trials associated with Allopurinol/Tranilast
NCT01109121
/ CompletedPhase 2
A Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Tranilast in Combination With Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
NCT01052987
/ CompletedPhase 2
A Randomized, Double-Blind, Crossover, Pharmacodynamic and Pharmacokinetic Drug Interaction Study of Tranilast in Combination With Allopurinol Compared With Tranilast Alone and Allopurinol Alone in Healthy Subjects With Hyperuricemia
100 Clinical Results associated with Allopurinol/Tranilast
Login to view more data
100 Translational Medicine associated with Allopurinol/Tranilast
Login to view more data
100 Patents (Medical) associated with Allopurinol/Tranilast
Login to view more data
100 Deals associated with Allopurinol/Tranilast
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperuricemiaPhase 2
United States
Nuon Therapeutics, Inc.Nuon Therapeutics, Inc.
01 Jun 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free